Metastastic breast carcinoma manifesting as postmenopausal uterine bleeding in a patient on tamoxifen therapy

European Journal of Gynaecological Oncology

Volumn 17, Issue 4, 1996, Pages 319-321

  Maymon, R ^a,b,d   Czernobilsky, B ^c   Lifschitz Mercer, B ^c   Schneider, D ^a   Bukovsky, I ^a   David, A ^d  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Patho Lab   (Israel)

^d Women's Health Centers   (Israel)

Author keywords

Breast carcinoma; Genital tract; Metastasis; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; BREAST CARCINOMA; CASE REPORT; CLINICAL FEATURE; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; METASTASIS; UTERUS BLEEDING; BREAST TUMOR; ENZYME IMMUNOASSAY; FATALITY; PATHOLOGY; POSTMENOPAUSE; UTERUS CANCER;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; POSTMENOPAUSE; TAMOXIFEN; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 0029662168     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ingle J. N.: "Tamoxifen and endometrial cancer: new challenges for an 'old" drug (editorial)". Gynecol. Oncol., 1994, 55, 161.
2. Giltrap S., Hall E., Newman M.: "Metastatic breast carcinoma arising in the endometrium: case report". Br. J. Obstet. Gynaecol., 1986, 93, 516.
3. Kumar N. B., Han W. R.: "Metastases to the uterine corpus from extragenital cancers' a clinicopathologic study of 63 cases". Cancer. 1982, 50, 2163.
4. Piura B., Bar David J., Goldstein J.: "Abnormal uterine bleeding as a presenting sign of metastatic signet ring cell carcinoma originating in the breast: case report". Br. J. Obstet. Gynaecol., 1985, 92, 645.
5. Le Bouedec G., Kouffrnann Ph., De Latour M., Fondrinier E., Cure H., Dauplat J.: "Metastases uterines des cancer du sein: a propas de 8 observations". J. Gynecol. Obstet. Biol. Reprod., 1991, 20, 349.
6. Afiat R., Lenain H., Vuagnat C., Michenet P., Luthier F., Maitre F., Grossetti D.: "Metastase d'un cancer du sein dans un leiomyoma uterine". J. Gynecol. Obstet. Biol. Reprod., 1993, 22, 243.
7. Di Banito L., Patriarca S., Alberico S.: "Breast carcinoma metastasizing to the uterus". Eur. J. Gynaecol. Oncol., 1985, 3, 211.
8. Ben Baruch G., Segal O., Serling J., Menczer J.: "Metastases to the endometrium from breast carcinoma". Eur. J. Gynaecol. Oncol. 1990, 11, 61.
9. Osborn M., Weber K.: "Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology". Lab. Invest., 1983, 48, 372.
10. Weingold A. B., Bolutugh S. M.: "Extragemtal metastases to the uterus". Am. J. Obstet. Gynecol., 1961, 82 (6), 1267.
11. Banooni F., Labes J., Goodman P. A.: "Uterine leiomyoma containing metastatic breast carcinoma". Am. J. Obstet. Gynecol., 1971, 111, 427.
12. Harris M., Howell A., Chrisshou M., Swindell RIC., Hudgon M., Sellwood R. A.: "A comparison of the metastatic patterns of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast". Br. J. Cancer, 1984, 50, 23.
13. Hardell L.: "Tamoxifen as a risk factor for carcinoma of corpus uteri". Lancet, 1988, ii, 563.